Abstract

The advancement of biotechnology has contributed a revolutionary change in field of gene editing for the medical research and industrial biotechnology. There are different types of technology developed in recent era but the contributions of CRISPR/Cas 9(Clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9) has the major role for the advancement of gene editing[1]. Anciently it was known as acquired immunity that protects the bacteria from plasmid infection. It switches the bacterial immune system to eliminate the odd genetic material[2]. The technology has enormous potential to edit the genomes very accurate and efficient manner. It also provides various applications in the field of medical research. There are several elements involved in the CRISPR process involved in the process of gene editing. The developments of the process increased its potential for various model organisms. The major two components of the process are generally the sgRNA(Synthetic Single guide RNA) and the Cas 9[3]. The sgRNA is associated with genome specific side targeting and the Cas 9 has the ability to form the side specific DNA cleavage. There are several advantages of this technology over the disease like cystic fibrosis, sickle cell anemia, hemophilia and single nucleotide based genetic disorders[4]

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call